Roche

Versant spinout lands $80M to go 'much broader' than the old Roche partnership that birthed it
Endpoints
Thu, 02/11/21 - 10:38 pm
Versant Ventures
Pipeline Therapeutics
Roche
Arthritis drug cuts deaths in hospitalized Covid-19 patients, major study shows
Stat
Thu, 02/11/21 - 10:50 am
Roche
tocilizumab
COVID-19
clinical trials
Heart disease devices lead latest batch of FDA breakthrough nods
Medtech Dive
Wed, 02/10/21 - 10:19 am
devices
FDA
cardiovascular disease
Roche
Puzzle Medical Devices
Alleviant Medical
Pedra Technology
Vascular Perfusion Solutions
Roche refreshingly cautious on Alzheimer's hopeful gantenerumab amid growing hype from rivals
Fierce Biotech
Fri, 02/5/21 - 10:52 am
Roche
gantenerumab
Alzheimer's disease
Why ipatasertib is not the Akt Astra wants to follow
EP Vantage
Thu, 02/4/21 - 10:39 am
Roche
Genentech
ipataserib
triple negative breast cancer
AstraZeneca
capivasertib
Roche chucks out phase 3 ipatasertib combo tests, midstage IL-33 asthma, BTKi arthritis trials in Q4 clear-out
Fierce Biotech
Thu, 02/4/21 - 10:36 am
Roche
earnings
cancer
autoimmune disease
drug development
Roche and Genentech's latest AI collaborator raises $25M Series A to reinvent one of the oldest cancer targets
Endpoints
Wed, 02/3/21 - 10:50 am
Roche
Genentech
artificial intelligence
machine learning
kinases
Reverie Labs
Roche eyes FDA filing after bispecific matches Eylea again
Fierce Biotech
Mon, 01/25/21 - 10:44 am
Roche
bispecifics
Regeneron
Eylea
clinical trials
faricimab
wet age-related macular degeneration
Further Studies Show Conflicting Results of Arthritis Drug for Severe COVID-19
BioSpace
Fri, 01/22/21 - 10:35 am
COVID-19
arthritis
Actemra
RoActemra
Roche
With patent concerns looming, Roche gets a new priority review on blockbuster IPF drug
Endpoints
Thu, 01/21/21 - 10:36 am
Roche
Esbriet
IPF
FDA
priority review
AZ/Daiichi Sankyo’s Enhertu gets second US cancer indication
Pharmaforum
Mon, 01/18/21 - 01:15 pm
AstraZeneca
Daiichi Sankyo
stomach cancer
Enhertu
Roche
Herceptin
10 key clinical trials to watch in the first half of 2021
BioPharma Dive
Sun, 01/17/21 - 05:01 pm
clinical trials
Novavax
AstraZeneca
JNJ
vaccines
COVID-19
Biomarin
Amgen
Merck
Pfizer
Roche
SAGE Therapeutics
Biogen
Vertex Pharmaceuticals
Roche, Sanofi arthritis drugs reduce death rates among sickest COVID-19 patients
Reuters
Thu, 01/7/21 - 11:18 pm
COVID-19
Roche
Actemra
Sanofi
Kevzara
Genentech Launches $1B+ RNA Collaboration with Ribometrix
Genetic Engineering News
Wed, 01/6/21 - 11:27 pm
Genentech
Roche
Ribometrix
small molecule drugs
drug discovery
R&D
Roche gets FDA breakthrough therapy status for tiragolumab plus Tecentriq
Pharmaceutical Business Review
Wed, 01/6/21 - 10:37 am
Roche
FDA
tiragolumab
Tecentriq
non-small cell lung cancer
breakthrough therapies
Merck, Bristol Myers, AstraZeneca and Roche lose bid to expand PD-1/L1 reach in China
Fierce Pharma
Wed, 12/30/20 - 10:53 am
Merck
Bristol-Myers Squibb
AstraZeneca
Roche
Keytruda
Opdivo
Imfinzi
Tecentriq
China
PD-1 inhibitors
Roche eyes an uncertain market for faricimab
EP Vantage
Tue, 12/22/20 - 10:49 am
Roche
faricimab
diabetic macular edema
Regeneron
Eylea
Roche's bispecific matches Regeneron's Eylea in phase 3 trials
Fierce Biotech
Mon, 12/21/20 - 11:02 am
Roche
faricimab
diabetic macular edema
clinical trials
Regeneron
Eylea
bispecific antibodies
MacroGenics wins FDA approval of breast cancer drug
BioPharma Dive
Thu, 12/17/20 - 06:15 pm
Margenza
Macrogenics
FDA
breast cancer
Roche
Herceptin
Roche's MS blockbuster Ocrevus, facing new Novartis competition, scores FDA nod for more-convenient infusion
Fierce Pharma
Tue, 12/15/20 - 08:29 pm
Roche
Novartis
Kesimpta
Ocrevus
MS
multiple sclerosis

Pages